Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

ABSTRACT: RATIONALE: Diagnostic imaging procedures, such as fludeoxyglucose F 18 PET, may be effective in detecting cancer or recurrence of cancer, or premalignant polyps. PURPOSE: This clinical trial is studying fludeoxyglucose F 18-PET imaging to see how well it works in determining protein and gene expression signatures in patients with premalignant polyps or colon cancer.

DISEASE(S): Colon Cancer,Colorectal Cancer,Neoplasm Of Uncertain Malignant Potential,Precancerous Conditions

PROVIDER: 2045806 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR